Vir Biotechnology
VIR
VIR
223 hedge funds and large institutions have $2.18B invested in Vir Biotechnology in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 81 increasing their positions, 74 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 74
0.86% less ownership
Funds ownership: 65.52% → 64.66% (-0.86%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
223
Holding in Top 10
3
Calls
$5.69M
Puts
$3.15M
Top Buyers
| 1 | +$27.8M | |
| 2 | +$21.5M | |
| 3 | +$12.5M | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$11.2M |
| 5 |
BlackRock
New York
|
+$6.65M |
Top Sellers
| 1 | -$46.2M | |
| 2 | -$11.5M | |
| 3 | -$8.96M | |
| 4 |
Temasek Holdings
Singapore
|
-$8.26M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.43M |